JNCI-Journal of the National Cancer Institute

JNCI-Journal of the National Cancer Institute

J NATL CANCER I
影响因子:7.2
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:UNITED STATES
出版社:Oxford University Press
发刊时间:0
发刊频率:Semimonthly
收录数据库:SCIE/Scopus收录
ISSN:0027-8874

期刊介绍

The Journal of the National Cancer Institute publishes peer-reviewed original research from around the world and is internationally acclaimed as the source for the most up-to-date news and information from the rapidly changing fields of cancer research and treatment. For the past several years, the JNCI has been ranked as one of the most-cited original-research cancer journals by the Institute of Scientific Information in its annual Journal Citation Reports.
《国家癌症研究所杂志》发表来自世界各地的同行评审原创研究,并在国际上享有盛誉,是癌症研究和治疗快速变化领域最新新闻和信息的来源。在过去的几年里,JNCI一直被科学信息研究所在其年度期刊引文报告中列为引用最多的原创研究癌症期刊之一。
年发文量 204
国人发稿量 14.34
国人发文占比 0.07%
自引率 -
平均录取率0
平均审稿周期 偏慢,4-8周
版面费 -
偏重研究方向 医学-肿瘤学
期刊官网 http://jnci.oxfordjournals.org/
投稿链接 http://jnci.oxfordjournals.org/feedback

期刊高被引文献

Sex-based heterogeneity in response to lung cancer immunotherapy: a systematic review and meta-analysis.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz094
Advanced intrahepatic cholangiocarcinoma: post-hoc analysis of the ABC-01, -02 and -03 clinical trials.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/JNCI/DJZ071
Targeting IDH1-Mutated Malignancies with NRF2 Blockade.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djy230
Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djy185
HER2-enriched subtype and ERBB2 expression in HER2-positive breast cancer treated with dual HER2 blockade.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz042
Targeted genomic profiling of acral melanoma.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz005
STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz036
Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djy234
Efficacy, safety, and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine: An interim analysis of a randomized clinical trial.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz074
Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz073
Acupuncture Versus Cognitive Behavioral Therapy for Insomnia in Cancer Survivors: A Randomized Clinical Trial.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/JNCI/DJZ050
Combining Tumor Microenvironment Modulating Nanoparticles with Doxorubicin to Enhance Chemotherapeutic Efficacy and Boost Antitumor Immunity.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djy131
A Reappraisal of Sex-Specific Cancer Survival Trends Among Adolescents and Young Adults in the United States.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djy140
Circulating 27-Hydroxycholesterol and Breast Cancer Risk: Results From the EPIC-Heidelberg Cohort.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djy115
Racial/Ethnic Differences in Lung Cancer Incidence in the Multiethnic Cohort Study: An Update.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djy206
Longitudinal e-cigarette and cigarette use among US youth in the PATH Study (2013-2015).
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz006
Prospective investigation of serum metabolites, coffee drinking, liver cancer incidence, and liver disease mortality.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz122
Impact of Sarcopenia on Adverse Outcomes After Allogeneic Hematopoietic Cell Transplantation.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/JNCI/DJY231
Premature Aging in Young Cancer Survivors.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djy229
Association of Aspirin and Nonsteroidal Anti-Inflammatory Drugs With Colorectal Cancer Risk by Molecular Subtypes.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djy170
The Association of Abdominal Adiposity with Mortality in Patients with Stage I-III Colorectal Cancer.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz150
Benzene Exposure Response and Risk of Myeloid Neoplasms in Chinese Workers: A Multicenter Case-Cohort Study.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djy143
Pregnancy-Associated Plasma Protein-A (PAPP-A) in Ewing Sarcoma: Role in Tumor Growth and Immune Evasion.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djy209
Patterns of Cause-Specific Mortality Among 2053 Survivors of Retinoblastoma, 1914-2016.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djy227
Expected Monetary Impact of Oncotype DX Score-Concordant Systemic Breast Cancer Therapy Based on the TAILORx Trial.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/JNCI/DJZ068
Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djy224
Factors that Explain Differences in Abstinence between Black and White Smokers: A Prospective Intervention Study.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz001
Impact of overweight and obesity on U.S. papillary thyroid cancer incidence trends (1995-2015).
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz202
Evaluating Lung Cancer Screening Uptake, Outcomes, and Costs in the United States: Challenges With Existing Data and Recommendations for Improvement.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djy228
Urinary Phthalate Biomarker Concentrations and Postmenopausal Breast Cancer Risk.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz002
COMT and Alpha-Tocopherol Effects in Cancer Prevention: Gene-Supplement Interactions in Two Randomized Clinical Trials.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djy204
Differences in Genomic Profiles and Outcomes between Thoracic and Adrenal Neuroblastoma.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz027
Impact of health insurance on stage at cancer diagnosis among adolescent and young adults.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz039
Race, Poverty, and Initial Implementation of Precision Medicine for Lung Cancer.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djy202
Vasectomy and prostate cancer risk: a 38-year nationwide cohort study.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz099
CDH1 on multigene panel testing: Look before you leap.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz229
Predicting Persistent Opioid Use, Abuse and Toxicity Among Cancer Survivors.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz200
The Association between hysterectomy and ovarian cancer risk: A population-based record-linkage study.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz015
Finding an Immunologic Beachhead in the Prostate Cancer Microenvironment.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djy145
A network meta-analysis of surgical treatment in patients with early breast cancer.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz105
Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz159
Factors associated with oncologist discussions of the costs of genomic testing and related treatments.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz173
Understanding the Profile of Cancer-Related Cognitive Impairments: A Critique of the Meta-Analyses.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz100
Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: a 23-year Prospective Study.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz195
Uncovering the role of hnRNP K, an RNA-binding protein, in B-cell lymphomas.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz078
Trends in mortality due to cancer in the US by age and county-level income, 1999-2015.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz123
Considerations when using breast cancer risk models for women with negative BRCA1/BRCA2 mutation results.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz194
What Should We Do Better? Lessons from Negative Results of a Biomarker Validation Study.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djy217
Annual versus biennial screening: diagnostic accuracy among concurrent cohorts within the Ontario Breast Screening Program.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz131
Mammographic Density Change and Risk of Breast Cancer.
来源期刊:Journal of the National Cancer InstituteDOI:10.1093/jnci/djz149

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
94.61%33.9%-8.16%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q1区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
ONCOLOGY
Q1

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学1区
ONCOLOGY 肿瘤学
1区
2023年12月升级版
医学1区
ONCOLOGY 肿瘤学
1区
2022年12月旧的升级版
医学1区
ONCOLOGY 肿瘤学
1区